368 related articles for article (PubMed ID: 18690105)
1. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.
Ricceri L; De Filippis B; Laviola G
Behav Pharmacol; 2008 Sep; 19(5-6):501-17. PubMed ID: 18690105
[TBL] [Abstract][Full Text] [Related]
2. Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome.
De Filippis B; Ricceri L; Laviola G
Genes Brain Behav; 2010 Mar; 9(2):213-23. PubMed ID: 19958389
[TBL] [Abstract][Full Text] [Related]
3. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
5. Rett syndrome: of girls and mice--lessons for regression in autism.
Glaze DG
Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
[TBL] [Abstract][Full Text] [Related]
6. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
7. Rett syndrome: new clinical and molecular insights.
Williamson SL; Christodoulou J
Eur J Hum Genet; 2006 Aug; 14(8):896-903. PubMed ID: 16865103
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
[TBL] [Abstract][Full Text] [Related]
9. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
10. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.
Belichenko PV; Wright EE; Belichenko NP; Masliah E; Li HH; Mobley WC; Francke U
J Comp Neurol; 2009 May; 514(3):240-58. PubMed ID: 19296534
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
12. Evidence for abnormal early development in a mouse model of Rett syndrome.
Santos M; Silva-Fernandes A; Oliveira P; Sousa N; Maciel P
Genes Brain Behav; 2007 Apr; 6(3):277-86. PubMed ID: 16848781
[TBL] [Abstract][Full Text] [Related]
13. Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets.
Mantis JG; Fritz CL; Marsh J; Heinrichs SC; Seyfried TN
Epilepsy Behav; 2009 Jun; 15(2):133-41. PubMed ID: 19249385
[TBL] [Abstract][Full Text] [Related]
14. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
[TBL] [Abstract][Full Text] [Related]
15. MeCP2 in neurons: closing in on the causes of Rett syndrome.
Caballero IM; Hendrich B
Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 mutation causes distinguishable phases of acute and chronic defects in synaptogenesis and maintenance, respectively.
Palmer A; Qayumi J; Ronnett G
Mol Cell Neurosci; 2008 Apr; 37(4):794-807. PubMed ID: 18295506
[TBL] [Abstract][Full Text] [Related]
17. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
18. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
20. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
Bartholdi D; Klein A; Weissert M; Koenig N; Baumer A; Boltshauser E; Schinzel A; Berger W; Mátyás G
Clin Genet; 2006 Apr; 69(4):319-26. PubMed ID: 16630165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]